2012 Featured Talks » Armed with Genomics, Is the Target in Sight for Myelodysplastic Syndromes
Armed with Genomics, Is the Target in Sight for Myelodysplastic Syndromes
Azra Raza, MD, MDS Center, Columbia University Medical Center
» Download Audio
Dr. Raza is the Director of the MDS Center at Columbia University in New York, NY. Dr. Raza completed her medical education in Pakistan, training in Internal Medicine at the University of Maryland, Franklin Square Hospital and Georgetown/VA Medical Center in Washington, D.C. and her fellowship in Medical Oncology at Roswell Park Cancer Institute in Buffalo, New York. She started her research in Myelodysplastic Syndromes (MDS) in 1982, moved briefly to Cincinnati, Ohio and then to Chicago, Illinois in 1992, where she established a highly productive translational research program in MDS. This program, along with a Tissue Repository with >50,000 human samples is now located at Columbia University. Dr. Raza has published the results of her research in high profile journals including Nature, New England Journal of Medicine, PLoS, Blood, Leukemia etc and is the author of 280 original articles, 20+ book chapters and a book devoted to MDS. Dr. Raza belongs to that rare group of unique investigators who are adept at both basic and clinical research. Her basic research has been strictly therapy-driven and is marked by Dr. Raza's tireless efforts to move the advances in the laboratory to the bedside with alacrity for the improvement of treatment outcome of MDS patients. Dr. Raza is well known internationally for several landmark observations related to the biology and treatment of MDS.